FDA NDA · NDA216099
PHYRAGO
Sponsor: HANDA THERAP
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA216099
TYPE
NDA
ORIGINAL APPROVAL
2023-12-05
LATEST ACTION
2026-10-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
PHYRAGO · ReferencePrescription
DASATINIB 100MG · TABLET · ORAL
PHYRAGO · ReferencePrescription
DASATINIB 70MG · TABLET · ORAL
PHYRAGO · ReferencePrescription
DASATINIB 20MG · TABLET · ORAL
PHYRAGO · ReferencePrescription
DASATINIB 140MG · TABLET · ORAL
PHYRAGO · ReferencePrescription
DASATINIB 80MG · TABLET · ORAL
PHYRAGO · ReferencePrescription
DASATINIB 50MG · TABLET · ORAL
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →